PDCD1 and leukemia: These results have raised a great deal of enthusiasm in the field of cancer therapy and a large number of clinical studies testing the safety and efficacy of agents targeting PD-1 or other inhibitory pathways in multiple types of tumors are currently ongoing.40 Our study provides pivotal information to move this strategy forward to leukemia treatment.